STOKELY DAN 4
4 · Ampio Pharmaceuticals, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
STOKELY DAN
CFO
Transactions
- Exercise/Conversion
Common Stock
2021-03-16$0.43/sh+40,000$17,200→ 68,315 total - Sale
Common Stock
2021-03-16$1.83/sh−40,000$73,048→ 28,315 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-16−40,000→ 318,000 totalExercise: $0.43Exp: 2029-08-20→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Options were granted and previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vests and becomes exerciserable on the date of grant, the remaining 50% of the stock option award vests and becomes exerciserable on July 31, 2020.